6th Annual Glycoscience Ireland Conference 2013, 8th November 2013
Conference Programme

6th Annual GlycoScience Ireland Meeting

Friday, 8th November 2013 

08:00 – 08:30  Coffee & Registration

08:30 – 09:00

Welcome – Professor Lokesh Joshi, AGRC

Opening Address – Professor Jim Browne, President, National University 

of Ireland, Galway

SFI – Dr Manus Ward

Session 1: Biopharma and Biomanufacturing

Chairperson :

0900 - 0930

Key Note Speaker: Professor John Lowe, Senior Director, Department of Pathology, Genentech Inc., California, USA

“Glycoengineering in Biopharma”

0930 - 1000

Key Note Speaker: Dr Reg Shaw, NIBRT, Dublin, Ireland

“TBC”

1000 - 1030

Dr Kirk Leister, Bristol Myers Squibb

“TBC”

1030 - 1045

Mr Oliver Grant, National University of Ireland, Galway.

“Using Virtual Glycan Array Screening to Define and Design Glycodiagnostic Specificity”

1045 - 1100

Mr Shashank Sharma, National University of Ireland, Galway.

“DNA aptamer-based glycan binders as analytical and diagnostic tools”

Coffee 1100 – 1130 (including Poster Session)

 

Session 2: Glyco-Biomaterials

Chairperson :  

1130 - 1200

Key Note Speaker: Professor Abhay Pandit, Network for Functional Biomaterials, National University of Ireland, Galway.

“Towards the next generation of biomaterials---using a glycobiology approach”

1200 - 1230

Professor Rhodri Ceredig, National University of Ireland, Galway.

“TBC”

1230 - 1245

Dr Michelle Kilcoyne, National University of Ireland, Galway.

“Glycobiomaterials: not just sticky and sweet”

1240 - 1300

Speaker to be confirmed

1300 – 1430 Lunch

 

Session 3: Clinical Glycotechnologies and Diagnostics

Chairperson :

1430 - 1500

Key Note Speaker: Professor  Robert Sackstein. Director, Harvard

Program of Excellence in Glycoscienc & Physician, Bone Marrow

Transplant Service, Brigham and Womens Hospital, Boston, USA

“GPS: Navigating the future of Medicine”

1500 - 1520

Professor Michael O’Dwyer, National University of Ireland, Galway

An emerging role for glycosylation in multiple myeloma disease progression”

1520 - 1540

Dr Zohar Yakhini, Agilent Technologies Inc

“TBC”

1540 – 1600

Dr Vilde Haakensen, Oslo Universitetssykehus HF, Oslo, Norway

Breast cancer systems biology and glycan-related alterations”

 

1600 – 1630 COFFEE BREAK

1630 - 1650

Dr Janne Lehtio, Karolinska Institute, Stockholm, Sweden.

“Comprehensive cellular proteome analysis in quest to connect proteomics with glycomics”

1650 - 1710

Professor Pauline Rudd, NIBRT, Dublin, Ireland

“When genomics meets glycomics a new picture emerges”

1710 - 1730

Paul Clarke, Dublin City University,

“TBC”

1730 - 1750

Sponsored Talk - Scienion

“TBC”